Status:
COMPLETED
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV Infection
Hepatitis C
Eligibility:
All Genders
18-90 years
Brief Summary
The principal goal of this research project is to evaluate the natural history of HCV and liver disease and its treatment in HIV-infected persons who use drugs. Research procedures will focus on deter...
Detailed Description
The principal goal of this research project is to evaluate the natural history of HCV and liver disease and its treatment in HIV-infected persons who use drugs. The recent availability of a novel, non...
Eligibility Criteria
Inclusion
- Current or prior drug use
- Reactive HCV antibody
- Reactive HIV antibody
Exclusion
- Women may not undergo FibroScan while pregnant
- Persons with implanted cardiac devices may not undergo FibroScan
Key Trial Info
Start Date :
March 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
828 Patients enrolled
Trial Details
Trial ID
NCT01448915
Start Date
March 31 2021
End Date
March 31 2021
Last Update
February 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287